NVCT
Nuvectis Pharma, Inc. · Healthcare
Director Matthew L. Kaplan bought $64K of Nuvectis Pharma, Inc.
Bought$64,240
$5.84Price
11,000Shares
+10%Stake
What NVCT did for a copier
- $1,000 copied at Thu, Nov 6 open, $5.89
- $1,321
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Dec 19 close.
Matthew L. Kaplan's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Nov 5. Filed Thu, Nov 6, 3:00 AM ET, before the open. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.